Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karsten Nysom

Showing results (41-50 of 82) with videos related to

Pageof 9
Sort By:
European Journal of Cancer (Oxford, England : 1990)|July 17, 2024
Precision cancer medicine platform trials: Concepts and design of AcSé-ESMARTBirgit Geoerger, Francisco Bautista, Nicolas André, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 27, 2019
Early Postoperative <sup>18</sup>F-FET PET/MRI for Pediatric Brain and Spinal Cord TumorsLisbeth Marner, Karsten Nysom, Astrid Sehested, et al.
BMC Cancer|June 23, 2017
Cerebellar mutism syndrome in children with brain tumours of the posterior fossaMorten Wibroe, Johan Cappelen, Charlotte Castor, et al.
Nature Medicine|October 19, 2023
AcSé-ESMART, a European precision cancer medicine proof-of-concept platform trialBirgit Geoerger, Xavier Paoletti, Francisco Bautista, et al.
Child'S Nervous System : Chns : Official Journal of the International Society for Pediatric Neurosurgery|June 27, 2022
Left-handedness should not be overrated as a risk factor for postoperative speech impairment in children after posterior fossa tumour surgery: a prospective European multicentre studyJonathan Kjær Grønbæk, Aske Foldbjerg Laustsen, Sebastian Toescu, et al.
Blood Advances|July 23, 2021
Response to upfront azacitidine in juvenile myelomonocytic leukemia in the AZA-JMML-001 trialCharlotte M Niemeyer, Christian Flotho, Daniel B Lipka, et al.
Neuro-Oncology Advances|July 16, 2020
Phase I study of vinblastine in combination with nilotinib in children, adolescents, and young adults with refractory or recurrent low-grade gliomaStephanie Vairy, Gwénaël Le Teuff, Francisco Bautista, et al.
The Lancet. Child & Adolescent Health|October 8, 2021
Postoperative speech impairment and surgical approach to posterior fossa tumours in children: a prospective European multicentre cohort studyJonathan Kjær Grønbæk, Morten Wibroe, Sebastian Toescu, et al.
European Journal of Cancer (Oxford, England : 1990)|March 15, 2022
ACCELERATE - Five years accelerating cancer drug development for children and adolescentsAndrew D J Pearson, Susan L Weiner, Peter C Adamson, et al.
Blood|October 17, 2020
A phase 1 study of inotuzumab ozogamicin in pediatric relapsed/refractory acute lymphoblastic leukemia (ITCC-059 study)Erica Brivio, Franco Locatelli, Marta Lopez-Yurda, et al.
Pageof 9

Showing results (41-50 of 82) with videos related to

Sort By:
Pageof 9
European Journal of Cancer (Oxford, England : 1990)|July 17, 2024
Precision cancer medicine platform trials: Concepts and design of AcSé-ESMARTBirgit Geoerger, Francisco Bautista, Nicolas André, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 27, 2019
Early Postoperative <sup>18</sup>F-FET PET/MRI for Pediatric Brain and Spinal Cord TumorsLisbeth Marner, Karsten Nysom, Astrid Sehested, et al.
BMC Cancer|June 23, 2017
Cerebellar mutism syndrome in children with brain tumours of the posterior fossaMorten Wibroe, Johan Cappelen, Charlotte Castor, et al.
Nature Medicine|October 19, 2023
AcSé-ESMART, a European precision cancer medicine proof-of-concept platform trialBirgit Geoerger, Xavier Paoletti, Francisco Bautista, et al.
Child'S Nervous System : Chns : Official Journal of the International Society for Pediatric Neurosurgery|June 27, 2022
Left-handedness should not be overrated as a risk factor for postoperative speech impairment in children after posterior fossa tumour surgery: a prospective European multicentre studyJonathan Kjær Grønbæk, Aske Foldbjerg Laustsen, Sebastian Toescu, et al.
Blood Advances|July 23, 2021
Response to upfront azacitidine in juvenile myelomonocytic leukemia in the AZA-JMML-001 trialCharlotte M Niemeyer, Christian Flotho, Daniel B Lipka, et al.
Neuro-Oncology Advances|July 16, 2020
Phase I study of vinblastine in combination with nilotinib in children, adolescents, and young adults with refractory or recurrent low-grade gliomaStephanie Vairy, Gwénaël Le Teuff, Francisco Bautista, et al.
The Lancet. Child & Adolescent Health|October 8, 2021
Postoperative speech impairment and surgical approach to posterior fossa tumours in children: a prospective European multicentre cohort studyJonathan Kjær Grønbæk, Morten Wibroe, Sebastian Toescu, et al.
European Journal of Cancer (Oxford, England : 1990)|March 15, 2022
ACCELERATE - Five years accelerating cancer drug development for children and adolescentsAndrew D J Pearson, Susan L Weiner, Peter C Adamson, et al.
Blood|October 17, 2020
A phase 1 study of inotuzumab ozogamicin in pediatric relapsed/refractory acute lymphoblastic leukemia (ITCC-059 study)Erica Brivio, Franco Locatelli, Marta Lopez-Yurda, et al.
Pageof 9